Opportunity Information: Apply for RFA HG 19 003
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), offered this funding opportunity to push the human genome reference forward into a true next-generation, pangenome-based resource. The main goal is to support research and development that produces practical genome reference representations that can capture essentially all human genomic variation, especially as the community generates more and more high-quality genome assemblies from diverse populations. Rather than relying on a single linear reference sequence, the opportunity centers on building representations that can handle many alternative sequences and variants at once, with the long-term aim of making population-scale genomic analysis more accurate, more inclusive, and more scalable.
A key scientific and technical focus is the idea of the pangenome as a graph. The general concept of graph-based genome references is already widely discussed in genomics, but NHGRI emphasized that major work still remained to make these ideas usable in day-to-day research and analysis. That includes refining how the reference is represented, how variation is encoded, how coordinate systems and annotations work in a non-linear framework, and how researchers can compute on these references efficiently. In plain terms, the FOA is looking for methods and implementations that do not just look good in theory, but actually perform well when used with large datasets and real analytical workflows.
The solicitation strongly prioritizes software development and practical implementation. NHGRI is looking for tools that demonstrate efficiency and scalability, including strong computational speed and the ability to work as the number of genomes and variants grows. Ease of use and the likelihood of broad adoption are also central: the software should be usable by the wider genomics community, not only by a small set of specialists. The expectation is that funded projects will help create a workable foundation for open science in genome referencing and analysis, enabling downstream tool builders and researchers to adopt the new reference models without prohibitive technical barriers.
Because NHGRI expects this area to become core infrastructure for genomics, the FOA is structured to fund multiple cooperative agreement projects that collectively help set benchmarks and standards. That means the program is not only about producing individual tools; it is also about shaping shared community expectations around performance, interoperability, data structures, specifications, and evaluation. By supporting several projects at once, NHGRI aims to accelerate convergence toward approaches that can serve as dependable building blocks for the field, rather than a fragmented ecosystem of incompatible formats and one-off implementations.
Open science is a primary requirement throughout. The opportunity calls for open-source tools, open standards, and openly available specifications, along with robust software engineering practices. The intention is that these products can be widely integrated across the broader genomics community and can support outside contributions, including from developers and researchers not directly funded under the award. At the same time, the FOA notes that robust design should allow the core work to serve as a foundation for independent implementations that may need stronger privacy and security controls. In other words, the default expectation is openness, but the architecture should not prevent privacy-preserving or security-enhanced use cases from being built on top of the core ideas.
Administratively, the opportunity is a discretionary NIH funding program under a cooperative agreement mechanism (U01), meaning NHGRI anticipates substantial programmatic involvement compared with a standard research grant. It is explicitly "Clinical Trial Not Allowed," signaling that the work should focus on computational methods, representations, and software infrastructure rather than prospective clinical interventions or trial activities. The funding opportunity is identified as RFA HG 19 003, associated with CFDA 93.172, and was created on January 30, 2019, with an original closing date of April 2, 2019.
Eligibility is broad and includes many types of domestic U.S. organizations and governments, such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses as well as small businesses), and multiple levels of government (state, county, city/township, special districts), plus independent school districts and public housing authorities/Indian housing authorities. It also includes federally recognized Native American tribal governments and other Native American tribal organizations. Beyond the typical NIH applicant pool, the FOA explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and even non-U.S. entities (foreign organizations). The overall message is that NHGRI wanted wide participation to help ensure the next reference representation is both technically strong and broadly useful across communities and settings.Apply for RFA HG 19 003
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
- This funding opportunity was created on 2019-01-30.
- Applicants must submit their applications by 2019-04-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: USAID/Burundi Orphans and Vulnerable Children (OVC) Local Activity
Previous opportunity: Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HG 19 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HG 19 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) Apply for PAR 19 175 Funding Number: PAR 19 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 177 Funding Number: PAR 19 177 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) Apply for RFA HS 19 001 Funding Number: RFA HS 19 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 110 Funding Number: RFA MH 20 110 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) Apply for RFA AI 19 012 Funding Number: RFA AI 19 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed) Apply for PAR 19 185 Funding Number: PAR 19 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships Apply for 720611 LOCAL PARTNER STRATEGY MEETING Funding Number: 720611 LOCAL PARTNER STRATEGY MEETING Agency: Zambia USAID-Lusaka Category: Health Funding Amount: Case Dependent |
| Tuberculosis Implementation Framework Agreement (TIFA) Apply for 7200AA19RFA00008 Funding Number: 7200AA19RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $300,000,000 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 19 019 Funding Number: RFA OD 19 019 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) Apply for PAR 19 189 Funding Number: PAR 19 189 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 115 Funding Number: RFA MH 20 115 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) Apply for PAR 19 204 Funding Number: PAR 19 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Not Allowed) Apply for PAR 19 203 Funding Number: PAR 19 203 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed) Apply for PAR 19 208 Funding Number: PAR 19 208 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) Apply for PAR 19 209 Funding Number: PAR 19 209 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 013 Funding Number: RFA AG 20 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 028 Funding Number: RFA AI 19 028 Agency: National Institutes of Health Category: Health Funding Amount: $850,000 |
| NINDS Institutional Research Training Program (T32) Apply for PAR 19 211 Funding Number: PAR 19 211 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) Apply for PAS 19 210 Funding Number: PAS 19 210 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA NS 19 015 Funding Number: RFA NS 19 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 19 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
